Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123267) titled 'A multicenter, prospective, single arm clinical trial on the safety and efficacy of sequential pressurized intraperitoneal aerosol chemotherapy with immunosuppressive agents and tocilizumab in the treatment of peritoneal metastatic adenocarcinoma' on April 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Guangdong Provincial People's Hospital
Condition:
Peritoneal metastatic adenocarcinoma
Intervention:
Group A (colorectal or appendix):None
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-05-01
Target Sample Size: Group A (colorectal or appendix)...